BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/4/2026 7:43:02 AM | Browse: 205 | Download: 660
Publication Name World Journal of Gastrointestinal Endoscopy
Manuscript ID 113576
Country Romania
ISSN 1948-5190 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry & Molecular Biology
Manuscript Type Case Control Study
Article Title Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management
Manuscript Source Invited Manuscript
All Author List Iulia Andreea Pelisenco, Alessandro Salvi, Giuseppina De Petro, Ioana Andreea Musat, Teodora Ecaterina Manuc, Cristian George Tieranu, Gabriel Becheanu, Elena Milanesi and Maria Dobre
ORCID
Author(s) ORCID Number
Teodora Ecaterina Manuc http://orcid.org/0000-0002-0589-4571
Cristian George Tieranu http://orcid.org/0000-0001-5348-0341
Gabriel Becheanu http://orcid.org/0000-0003-1627-8907
Elena Milanesi http://orcid.org/0000-0003-2753-3395
Maria Dobre http://orcid.org/0000-0002-1376-4021
Funding Agency and Grant Number
Funding Agency Grant Number
Romanian Ministry of Research, Innovation and Digitization PN 23.16.02.04
Corresponding Author Elena Milanesi, Assistant Professor, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Eroii Sanitari Bvd., no. 8, sector 5, Bucharest 050474, Romania. elena.k.milanesi@gmail.com
Key Words Endocannabinoid system; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Gene expression
Core Tip The anti-inflammatory benefits of cannabinoids could serve as a potential new treatment for patients suffering from inflammatory bowel disease (IBD). In this study, we analyzed the expression level of 10 genes belonging to the endocannabinoid system in colonic mucosa from IBD patients vs controls. CNR2, FAAH, GPR18, GPR55, PPARG, and TRPV1 genes were dysregulated in the entire IBD cohort. Stratifying patients into Crohn's disease and ulcerative colitis subgroups, we found that the same 6 genes were dysregulated in at least one comparison. Further analysis of the endocannabinoid system could bridge the gap between preclinical findings and its role in gastrointestinal diseases.
Publish Date 2026-02-04 07:43
Citation

Pelisenco IA, Salvi A, De Petro G, Musat IA, Manuc TE, Tieranu CG, Becheanu G, Milanesi E, Dobre M. Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management. World J Gastrointest Endosc 2026; 18(2): 113576

URL https://www.wjgnet.com/1948-5190/full/v18/i2/113576.htm
DOI https://dx.doi.org/10.4253/wjge.v18.i2.113576
Full Article (PDF) WJGE-18-113576-with-cover.pdf